Northwest Biotherapeutics INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
OQB
Northwest Biotherapeutics, Inc. announces its 2025 Annual Meeting of Stockholders to vote on director election, auditor ratification, an increase in authorized common stock, and executive compensation.
OQB
DEFA14A: Northwest Biotherapeutics Announces Audio-Only Access Details for June 29, 2024 Annual Meeting
Northwest Biotherapeutics provides instructions for stockholders to access the Annual Meeting on June 29, 2024, via an audio-only link or telephonically, emphasizing the need to vote proxies in advance.
OQB
Northwest Biotherapeutics is seeking stockholder approval for option awards granted to executives and directors in 2020, amidst a legal challenge questioning the fairness and process of these awards.